Chronic Liver Disease
Biochemical tests could supplant liver biopsies for diagnosing liver fibrosis
Published in Hepatitis Weekly, November 22nd, 2004
"Laboratory tests for the noninvasive diagnosis of liver fibrosis were studied extensively in the past. However, no test is yet accepted to replace liver biopsy as the gold standard. The establishment of widely accepted semiquantitative histologic scoring systems for the grading and staging of chronic liver disease (e.g, Ishak, Metavir and Scheuer) was paralleled by a significant upturn of research in circulating markers of liver fibrosis," scientists writing in the journal Expert Review of Molecular Diagnostics state.
"We are now experiencing the renaissance of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-11-22)
More Articles from Hepatitis Weekly
- Chronic Hepatitis B
Hepatitis B virus DNA in the liver correlates with extent of liver injury - Diagnostics
A new assay improves the timeliness and sensitivity of hepatitis C detection - Diagnostics
Core antigen assay can't confirm active hepatitis C virus infection - Epidemiology
The minimum spanning tree model tracks the source of hepatitis C outbreaks - Oncology
KL-6 is a serological marker for liver cancer in patients with hepatitis C - Addiction Medicine
Injection drug users often develop hepatitis C virus superinfections - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
